Translational Drug Development (TD2)
Hannah Y. is an experienced professional in the field of database programming and clinical data management, currently serving as a Senior Database Programmer at Translational Drug Development (TD2) since November 2017. Hannah's responsibilities include providing technical support for electronic data capture (EDC) systems and independently building EDC systems for clinical trials. Prior to this role, Hannah worked as an eClinical Data Scientist at DOCS, where responsibilities included designing and maintaining clinical trials using EDC systems, and served as a Senior System Analyst at Abbott Vascular and Quintiles, focusing on eCRF design and EDC implementations. Hannah began a career as a System Analyst at Computer Horizons Corps. Education includes a Master of Science in Computer Science from the University of North Carolina at Charlotte and an MBA in Management Business Administration from Meredith College.
This person is not in the org chart
This person is not in any offices
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.